CL
XERS icon

CSS LLC’s Xeris Biopharma Holdings XERS Stock Holding History

CSS LLC’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-18,124
Closed -$40.1K – 1012
2024
Q1 		$40.1K Buy
+18,124
New +$46.9K ﹤0.01% 743
2023
Q4 		– Sell
-24,991
Closed -$46.5K – 948
2023
Q3 		$46.5K Hold
24,991
– – ﹤0.01% 728
2023
Q2 		$65.5K Hold
24,991
– – ﹤0.01% 766
2023
Q1 		$40.7K Hold
24,991
– – ﹤0.01% 616
2022
Q4 		$33.2K Sell
24,991
-14,840
-37% -$20.9K ﹤0.01% 756
2022
Q3 		$62K Sell
39,831
-27,503
-41% -$45.5K ﹤0.01% 863
2022
Q2 		$104K Hold
67,334
– – ﹤0.01% 886
2022
Q1 		$172K Sell
67,334
-2,500
-4% -$6.11K 0.01% 870
2021
Q4 		$205K Buy
+69,834
New +$151K 0.01% 897

Other funds holding XERS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return

CSS LLC's XERS Position: Q2 2024 in Review

CSS LLC sold out of Xeris Biopharma Holdings (XERS) in Q2 2024, closing a stake of 18,124 shares — an estimated $40.1K sold.

CSS LLC first reported a position in XERS in Q4 2021 and held it in 9 quarters. The position peaked at $205K in Q4 2021. 134 funds tracked by Wall St. Rank hold XERS as of Q2 2024.

  • CSS LLC reported no remaining Xeris Biopharma Holdings position as of Q2 2024 after selling out during the quarter.
  • CSS LLC sold 18,124 Xeris Biopharma Holdings shares in Q2 2024, an estimated $40.1K.
  • CSS LLC first reported a position in Xeris Biopharma Holdings in Q4 2021 and held it in 9 quarters.
  • CSS LLC's Xeris Biopharma Holdings position peaked at $205K in Q4 2021.
  • 134 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2024.

Based on CSS LLC's 13F filing for Q2 2024, filed 14 Aug 2024.